Research and Development

Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …

What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …

Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …

A round-up of recent developments in the contract research sector, featuring updates from PRA, Cetero Labs, Covance/BML, Harlan Labs CRS …

Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial.  The news comes after …

Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …

Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer.  The 42-year-old succeeds Dr Jean-Luc Lowinski, …

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …

Rapid uptake of anti-clotting drug Pradaxa in the US has helped Boehringer Ingelheim enjoy a strong year, and looks set to …

Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced.  The company said …

A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …

When companies complain that they can’t find enough good people, the cause, in our view, is most likely to be …

Quintiles, the biopharmaceutical services company, has appointed Tom Pike as its new chief executive, effective from 30 April. The appointment …